Syndax Pharmaceuticals (SNDX) PT Raised to $34 at Barclays
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $18.18 -3.4%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Barclays analyst Peter Lawson raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $34.00 (from $31.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
